Literature DB >> 31982628

Rehabilitation, optimized nutritional care, and boosting host internal milieu to improve long-term treatment outcomes in tuberculosis patients.

Onno W Akkerman1, Lies Ter Beek2, Rosella Centis3, Markus Maeurer4, Dina Visca5, Marcela Muñoz-Torrico6, Simon Tiberi7, Giovanni Battista Migliori8.   

Abstract

BACKGROUND: The holistic management of tuberculosis (TB) patients can improve life expectancy and lost organ function. REHABILITATION: Chronic sequelae are very common among patients who survive TB, which can lead to a further decline in lung function. There is still no guidance for 'cured' patients with impaired lung function who need pulmonary rehabilitation. Additional tests for evaluation should be given after the end of treatment, as recent studies have shown the good effect of pulmonary rehabilitation for TB patients. OPTIMIZED NUTRITIONAL CARE: Malnutrition is very common among TB patients and is related to malabsorption. The latter can cause lower drug exposure, which may result in treatment failure, increasing the risk of death, and can lead to acquired drug resistance. Malnutrition should be assessed according to the Global Leadership Initiative on Malnutrition (GLIM) criteria and the diagnosis should lead to an individualized treatment plan, including sufficient proteins and preferably in combination with adequate training. PROTECTIVE IMMUNE RESPONSES: Under normal circumstances, most immune cells use a glucose-based mechanism to generate energy. Therefore the patient's nutritional status is a key factor in shaping immune responses. Disease-related malnutrition leads to proteolysis and lipolysis. In the end, the identification of individuals who will benefit from immune-modulatory strategies may lead to clinically relevant markers.
Copyright © 2020 The Authors. Published by Elsevier Ltd.. All rights reserved.

Entities:  

Keywords:  Disease-related malnutrition; Immune response; Pulmonary rehabilitation; Tuberculosis

Mesh:

Year:  2020        PMID: 31982628     DOI: 10.1016/j.ijid.2020.01.029

Source DB:  PubMed          Journal:  Int J Infect Dis        ISSN: 1201-9712            Impact factor:   3.623


  5 in total

1.  Clinical standards for drug-susceptible pulmonary TB.

Authors:  O W Akkerman; R Duarte; S Tiberi; H S Schaaf; C Lange; J W C Alffenaar; J Denholm; A C C Carvalho; M S Bolhuis; S Borisov; J Bruchfeld; A M Cabibbe; J A Caminero; I Carvalho; J Chakaya; R Centis; M P Dalcomo; L D Ambrosio; M Dedicoat; K Dheda; K E Dooley; J Furin; J-M García-García; N A H van Hest; B C de Jong; X Kurhasani; A G Märtson; S Mpagama; M Munoz Torrico; E Nunes; C W M Ong; D J Palmero; R Ruslami; A M I Saktiawati; C Semuto; D R Silva; R Singla; I Solovic; S Srivastava; J E M de Steenwinkel; A Story; M G G Sturkenboom; M Tadolini; Z F Udwadia; A R Verhage; J P Zellweger; G B Migliori
Journal:  Int J Tuberc Lung Dis       Date:  2022-07-01       Impact factor: 3.427

2.  Utilisation of nutritional support scheme among the patients of tuberculosis: A myth or a truth.

Authors:  Jarina Begum; Y Neelima; Syed I Ali; Satyajit Pattnaik; Dhananjaya Sharma
Journal:  J Family Med Prim Care       Date:  2020-12-31

3.  Persistent chronic respiratory symptoms despite TB cure is poorly correlated with lung function.

Authors:  B W Allwood; M Stolbrink; N Baines; E Louw; D T Wademan; A Lupton-Smith; S Nel; D Maree; S Mpagama; M Osman; F M Marx; G Hoddinott; M Lesosky; J Rylance; K Mortimer
Journal:  Int J Tuberc Lung Dis       Date:  2021-04-01       Impact factor: 2.373

4.  Effect of Health Education Combined with Dietary Guidance on Nutritional Indicator, Immune Level, and Quality of Life of Patients with Pulmonary Tuberculosis.

Authors:  Baojuan Hu; Guoxia Ren; Lin Zhao
Journal:  Comput Math Methods Med       Date:  2021-09-29       Impact factor: 2.238

Review 5.  Mycobacterium tuberculosis and Pulmonary Rehabilitation: From Novel Pharmacotherapeutic Approaches to Management of Post-Tuberculosis Sequelae.

Authors:  Andreea-Daniela Meca; Liliana Mititelu-Tarțău; Maria Bogdan; Lorena Anda Dijmarescu; Ana-Maria Pelin; Liliana Georgeta Foia
Journal:  J Pers Med       Date:  2022-04-02
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.